Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR Co-Founder Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the biotech industry landscape post-pandemic. She also gives her reaction to UC Berkeley losing the CRISPR patent battle against MIT and Harvard.
-
- 1
Francisco Gimeno - BC Analyst The bio tech industry continues unabated developing different innovative technologies which are transforming not just science but our way to see life. CRISPR technology (with its pro and contras) is one of them. This is just the beginning. We should expect the commercialization of the technology once prices are affordable, as it happened with the genoma some decade ago. It is going to deeply impact our society.